Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 45.96% ano a ano.
Avaliação Justa
O PE mais recente da empresa é 11.26, em uma faixa percentil média de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 34.93M ações, uma redução de 15.55% em relação ao trimestre anterior.
Mantido por John Hussman
O Super Investidor John Hussman possui 12.83K ações desta empresa.
Baixa Atividade de Mercado
A empresa tem menor interesse dos investidores, com uma taxa de giro de 20 dias de -0.03.